Kawasaki shock syndrome presenting as toxic shock syndrome

International Journal of Rheumatic Diseases

Volumn 16, Issue 4, 2013, Pages 480-482

  Saha, Abhijeet ^a   Khalil, Sumaira ^a   Kapoor, Kanika ^a   Gupta, Anshul ^a   Dubey, Nand K ^a  

^a DR RAM MANOHAR LOHIA HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; DOBUTAMINE; DOPAMINE; IMMUNOGLOBULIN;

ADOLESCENT; CASE REPORT; CHAPPED LIPS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONJUNCTIVITIS; CONTRAST ENHANCEMENT; DISEASE DURATION; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; EYE REDNESS; FEMALE; FEVER; FLUID RESUSCITATION; FOLLOW UP; GENERALIZED EDEMA; HEART EJECTION FRACTION; HUMAN; HYPOTENSION; KAWASAKI DISEASE SHOCK SYNDROME; LETTER; LEUKOCYTE COUNT; LYMPHADENOPATHY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERICARDIAL EFFUSION; PRIORITY JOURNAL; QRS COMPLEX; RIGHT CORONARY ARTERY; SACCULAR ANEURYSM; SHOCK; SINUS TACHYCARDIA; ST SEGMENT DEPRESSION; SUBCUTANEOUS TISSUE; TACHYCARDIA; TACHYPNEA; TOXIC SHOCK SYNDROME; TREATMENT DURATION; VOMITING;

ADOLESCENT; ASPIRIN; COMORBIDITY; CORONARY ANEURYSM; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MUCOCUTANEOUS LYMPH NODE SYNDROME; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 84883460527     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12119     Document Type: Letter

References (11)

1. Burns JC, Glode MP (2004) Kawasaki syndrome. Lancet 364, 533-44.
2. Harnden A, Takahashi M, Burgner D (2009) Kawasaki disease. Br Med J 338, 1133-8.
3. Kanegaye JT, Wilder MS, Molkara D et al. (2009) Recognition of Kawasaki shock syndrome. Pediatrics 123, e783-9.
4. Kato H, Inoueo O, Akagi T (1988) Kawasaki disease: cardiac problems and management. Pediat Rev 9, 209-17.
5. Shulman ST, De Inocencio J, Hirsch R (1995) Kawasaki disease. Pediatr Clin North Am 42, 1205-22.
6. Gámez-González LB, Murata C, Muñoz-Ramírez M, Yamazaki-Nakashimada M (2013) Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children. Eur J Pediatr 172, 337-42.
7. Dominguez SR, Friedman K, Seewald R, Anderson MS, Willis L, Golde MP (2008) Kawasaki disease in a pediatric intensive care unit: a case-control study. Pediatrics 122, e786-90.
8. Research Committee on Kawasaki Disease (1984) Report of subcommittee of standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo, Japan.
9. Takahashi M, Mason W, Lewis AB (1987) Regression of Coronary aneurysms in patients with Kawasaki syndrome. Circulation 75, 387-94.
10. Gatterre P, Oualha M, Dupic L et al. (2012) Kawasaki disease: an unexpected etiology of shock and multiple organ dysfunction syndrome. Intensive Care Med 38, 872-8.
11. Kato H, Sugimura T, Akagi T et al. (1996) Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients. Circulation 94, 1379-85.